as on September 17, 2025 at 4:01 pm IST
Market Cap
₹11.60 Cr
Return on Equity (ROE)
0.57
PE Ratio (TTM)
0Return on capital employed (ROCE)
0.57
Beta (LTM)
0.35
P/B Ratio
2.99
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-84.62
EPS (TTM)
0Sector
Miscellaneous
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Genomic Valley Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 11.60 | 20.85% | 0.00 | -1 | 2 | |
NA | 6,431.97 | 39.31% | 0.62 | 21 | 235 | |
NA | 52.50 | 28.32% | 0.43 | 18 | 11 | |
NA | 54.27 | 527.45% | 0.00 | 1 | 1 | |
NA | 6.07 | 19.86% | 0.00 | -1 | NA |
Search interest for Genomic Valley Biotech Ltd Stock has increased by 47% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:47% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Genomic Valley Biotech Ltd.
Genomic Valley Biotech Ltd’s net profit fell -84.62% since last year same period to ₹0.02Cr in the Q1 2025-2026. On a quarterly growth basis, Genomic Valley Biotech Ltd has generated 125% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 53.22% to 53.28% in Jun 2025 quarter
Against Peers
In the last 3 years, Kaveri Seed Company Ltd has given 159.6% return, outperforming this stock by 142.6%
Against Peers
In the last 1 year, Kaveri Seed Company Ltd has given 11.0% return, outperforming this stock by 61.4%
Promoter Holding Down
Promoters have decreased holdings from 46.78% to 46.72% in Jun 2025 quarter
Price Dip
In the last 1 month, Genomic Valley stock has moved down by -11.5%
Organisation | Genomic Valley Biotech Ltd |
Headquarters | New Delhi |
Industry | Miscellaneous |
CEO | Yogesh Agrawal |
E-voting on shares | Click here to vote |
Genomic Valley Biotech Ltd share price today stands at ₹37 as on at the close of the market. Genomic Valley Biotech Ltd share today touched a day high of ₹38.5 and a low of ₹37.
Genomic Valley Biotech Ltd touched a 52 week high of ₹108.15 and a 52 week low of ₹37. Genomic Valley Biotech Ltd share price today i.e. is closed at ₹37, which is -65.79% down from its 52 week high and 0.00% up from its 52 week low.
Genomic Valley Biotech Ltd market capitalisation is ₹11.60 Cr as on .
To buy Genomic Valley Biotech Ltd shares, you need to follow these steps:
Genomic Valley Biotech Ltd trading volume is 898.00 as on . This means that 898.00 shares of Genomic Valley Biotech Ltd were bought and sold on the stock market during today's trading session.